Susceptible Dose-Dependent Dosing Guidance: Daptomycin and Ceftaroline
Susceptible Dose-Dependent Dosing Guidance: Daptomycin and Ceftaroline
Summary
The Clinical & Laboratory Standards Institute (CLSI) includes a susceptible dose-dependent (SDD) category for certain drug and organism combinations. The SDD is a breakpoint category for which the susceptibility of an isolate depends on the dosing regimen used. For isolates with SDD susceptibility results, dosing regimens that achieve higher drug exposure are necessary. For the highest probability of adequate coverage of an SDD isolate, consideration should be given to using the maximum, literature-supported dosing regimens.1
UNC Medical Center's Microbiology Lab includes an SDD category for E. faecium: daptomycin and S. aureus: ceftaroline.
SDD: E. faecium--Daptomycin
Background The FDA-approved dosing for daptomycin was originally based on treatment of infections due to staphylococci. Though not a labeled indication, daptomycin is an important antibiotic for treatment of infections due to vancomycin-resistant Enterococcus. Daptomycin MICs for E. faecium are often higher than MICs for other Gram-positive organisms. Studies have found that applying labeled daptomycin dosing to severe infections due to E. faecium lead to poorer outcomes.2 In two cohort studies, high-dose daptomycin was associated with lower mortality in patients with vancomycin-resistant E. faecium bacteremia. "High-dose" was considered to be 10 mg/kg daily and 9mg/kg daily, respectively. In both studies, the daptomycin MIC was 4 mg/L in ~ 70% of patients.3,4 Studies have also shown that high-dose daptomycin is generally well-tolerated and safe. It is recommended to monitor creatine kinase (CK) weekly in all patients receiving daptomycin.5
Recommendations
Daptomycin MIC (mg/L) breakpoints for Enterococcus faecium1
Susceptible (S)
Susceptible dosedependent (SDD)
Resistant (R)
Daptomycin MIC
-
4
8
Recommended dosing*
-
8-12 mg/kg Q24H
-
*Recommended dosing is for adult patients with normal renal function. Please see UNC Pharmacy Clinical Guidelines for dosing adjustments in
patients with renal dysfunction:
Dose based on actual total body weight for non-obese patients. For BMI > 30 use adjusted body weight. AdjBW= IBW + 0.4(TBW-IBW)
For serious infections caused by E. faecium reported as SDD (MIC 4 mg/L), dosing regimens of daptomycin 8-12 mg/kg per day are recommended. In these cases, consider consultation with Infectious Diseases. These recommendations apply to adult patients only. Equivalent high-dose daptomycin strategies have not been studied in children. Consider consultation with Pediatric Infectious Diseases. For serious infections due to other Enterococcus spp. or S. aureus, highdose daptomycin strategies may also be appropriate. Contact the Antimicrobial Stewardship Program (ASP) for assistance with daptomycin dosing (pager 216-2398).
References: 1. CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 29th ed. CLSI supplement M100. Wayne, PA: Clinical Laboratory Standards Institute; 2019. 2. Moise PA, Sakoulas G, McKinnell JA, et al. Clinical outcomes of daptomycin for vancomycin-resistant Enterococcus bacteremia. Clin Ther. 2015;37(7):14431453. 3. Britt NS, Potter EM, Patel N, Steed ME. Comparative effectiveness and safety of standard-,medium-, and high-dose daptomycin strategies for the treatment of vancomycin-resistant enterococcal bacteremia among Veterans Affairs patients. Clin Infect Dis. 2017;64(5):605-613. 4. Chuang YC, Lin HY, Chen PY, et al. Effect of daptomycin dose on the outcome of vancomycin-resistant, daptomycin-susceptible Enterococcus faecium bacteremia. Clin Infect Dis. 2017;64(8):1026-1034. 5. Seaton RA, Menichetti F, Dalekos G, et al. Evaluation of effectiveness and safety of high-dose daptomycin: results from patients included in the European Cubicin? Outcomes Registry and Experience. Adv Ther. 2015;32:1192-1205. 6. Fox AN, Smith WJ, Kupiec KE, et al. Daptomycin dosing in obese patients: analysis of adjusted versus actual body weight. Ther Adv Infect Dis 2019;6:1-10. 7. Dvorchik BH, Damphousse D. The pharmacokinetics of daptomycin in moderately obese, morbidly obese, and matched nonobese subjects. J Clin Pharmacol. 2005;45:48-56.
Prepared by the UNC Medical Center Antimicrobial Stewardship Program
Updated 6-17-2019
SDD: S. aureus: Ceftaroline
Background
The FDA-approved adult dosing for ceftaroline is 600 mg IV every 12 hours given over 5-60 minutes. Most S. aureus isolates in the United States have a ceftaroline MIC of < 1 mg/L, however isolates with higher MICs have been reported.1
In the Phase 3 clinical trials using doses of ceftaroline 600 mg IV every 12 hours, the majority of S. aureus clinical isolates had ceftaroline MICs of < 1 mg/L.2 Pharmacokinetic/pharmacodynamics (PD/PD) modeling data support dosage regimens of 600 mg IV every 8 hours infused over 2 hours for S. aureus organisms with MICs of 2-4 mg/L.2 In a randomized
controlled trial, this higher dosing regimen was shown to be safe and effective in patients with complicated skin and soft tissue infections with evidence of systemic inflammation.3
Recommendations
Ceftaroline MIC (mg/L) breakpoints for Staphylococcus aureus4
Susceptible (S)
Susceptible dosedependent (SDD)
Resistant (R)
Ceftaroline MIC
1
2-4
8
Recommended dosing*
600 mg every 12 hours 600 mg every 8 hours over
over 5-60 minutes
2 hours
-
*Recommended dosing is for adult patients with normal renal function. Please see UNC Pharmacy Clinical Guidelines for dosing adjustments in
patients with renal dysfunction:
For infections caused by S. aureus reported as SDD (MIC 2-4 mg/L), ceftaroline 600 mg every 8 hours (2 hour infusion) is recommended. In these cases, consider consultation with Infectious Diseases. These recommendations apply to adult patients only. Equivalent high-dose ceftaroline strategies have not been studied in children. Consider consultation with Pediatric Infectious Diseases.
References: 1. Jones RN, Mendes RE, Sader HS. Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study. J Antimicrob Chemother 2010; 65:17-31. 2. Das S, Li J, Iaconis J. et al. Ceftaroline fosamil doses and breakpoints for S. aureus in complicated skin and soft tissue infections. J Antimicrob Chemother 2018; 74:425-431. 3. Dryden, M, Zhang, Y, Wilson Y., et al. A phase III randomized controlled non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities. J Antimicrob Chemother. 2016; 71:3575-3584. 4. CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 29th ed. CLSI supplement M100. Wayne, PA: Clinical Laboratory Standards Institute; 2019.
Prepared by the UNC Medical Center Antimicrobial Stewardship Program
Updated 6-17-2019
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- adult surgical antibiotic prophylaxis protocol ≥18 years
- audiological monitoring of patients receiving ototoxic drugs
- evidence based practice center systematic review protocol project title
- last approval date policy title pharmacist managed intravenous to
- antimicrobial surgical prophylaxis michigan medicine
- antibiotic policy aiims jodhpur
- penicillin allergy skin testing protocol
- orthopedic antibiotic protocols vumc
- antibiotic sensitivity testing i objectives ii introduction
- protocol for the use of intravenous iron sucrose venofer
Related searches
- light dependent and light independent
- light dependent and independent reaction
- independent and dependent variables worksheet
- examples of independent and dependent variables
- constant independent and dependent variable
- independent variable and dependent examples science
- example dependent and independent variable
- independent and dependent variables problem
- dependent and independent variables exercise
- independent and dependent quantities examples
- research questions using dependent and independent variables
- examples of independent dependent and controlled variables